Pharma Stocks
-
Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?
Shares of pharma companies rallied up to 7% on Wednesday as strong earnings, a weakening rupee, and other supportive factors…
Read More » -
FDA Approval Of Tessie Puts Orion’s Animal Health Potential In Focus
Orion Oyj (HLSE:ORNBV) has received FDA approval for its proprietary veterinary drug Tessie (tasipimidine) for use in the U.S. market.…
Read More » -
Chinese pharma player in focus after recent business u
Huadong Medicine Co Ltd has remained active with business and product updates, drawing attention to its role in China’s pharmaceutical…
Read More » -
Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands)
Cosette Pharmaceuticals, Inc., a U.S.-based, branded specialty pharmaceutical company, announced today it has appointed David Bell as Chief Commercial Officer…
Read More » -
Aurobindo Pharma Sees Sharp Open Interest Surge Signallin…
Open Interest and Volume Dynamics The latest data reveals that Aurobindo Pharma’s open interest (OI) in derivatives rose sharply by…
Read More » -
Gland Pharma Limited Just Recorded A 8.8% EPS Beat: Here’s What Analysts Are Forecasting Next
A week ago, Gland Pharma Limited (NSE:GLAND) came out with a strong set of full-year numbers that could potentially lead…
Read More » -
Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Lower Today
What Happened? Shares of pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) fell 2.8% in the morning session after Wells Fargo downgraded the…
Read More » -
Royalty Pharma (RPRX) Benefits from Biotech Funding Gap with Rising Returns and Market Dominance
Latitude Investment Management, an investment management firm, released its fourth-quarter 2025 investor letter. A copy of the letter can be…
Read More » -
Q1 2026 beat, raised outlook and steady dividend attract fresh attenti
GSK plc has surprised the market with better-than-expected Q1 2026 results, a guidance increase and a maintained dividend, putting the…
Read More » -
earnings momentum and US injectables footprint in fo
Generic drug maker Hikma Pharmaceuticals PLC has been drawing attention with recent earnings, a solid injectables pipeline and growing US…
Read More »